Cargando…
Autophagy in stromal fibroblasts promotes tumor desmoplasia and mammary tumorigenesis
Autophagy inhibitors are currently being evaluated in clinical trials for the treatment of diverse cancers, largely due to their ability to impede tumor cell survival and metabolic adaptation. More recently, there is growing interest in whether and how modulating autophagy in the host stroma influen...
Autores principales: | Rudnick, Jenny A., Monkkonen, Teresa, Mar, Florie A., Barnes, James M., Starobinets, Hanna, Goldsmith, Juliet, Roy, Srirupa, Bustamante Eguiguren, Sofía, Weaver, Valerie M., Debnath, Jayanta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8247603/ https://www.ncbi.nlm.nih.gov/pubmed/34168038 http://dx.doi.org/10.1101/gad.345629.120 |
Ejemplares similares
-
Autophagy and Tumorigenesis
por: Roy, Srirupa, et al.
Publicado: (2010) -
Mebendazole disrupts stromal desmoplasia and tumorigenesis in two models of pancreatic cancer
por: Williamson, Tara, et al.
Publicado: (2021) -
Reprogramming of stromal fibroblasts by SNAI2 contributes to tumor desmoplasia and ovarian cancer progression
por: Yang, Zongyuan, et al.
Publicado: (2017) -
The complexities of breast cancer desmoplasia
por: Walker, Rosemary A
Publicado: (2001) -
Desmoplasia and Chemoresistance in Pancreatic Cancer
por: Schober, Marvin, et al.
Publicado: (2014)